Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marianeve Polimeno"'
Autor:
G. Botti, Roberto Pacelli, Anna Nappi, Luisa Circelli, Crescenzo D'Alterio, Stefania Scala, Giosuè Scognamiglio, Sara Santagata, Marianeve Polimeno, Guglielmo Nasti, Manuel Conson, Francesco Izzo, Alessandro Ottaiano, Emilia Vuttariello, Gerardo Botti, Maria Napolitano, Fabiana Tatangelo, Chiara De Divitiis
A neoadjuvant clinical trial was previously conducted in patients with resectable colorectal cancer liver metastases (CRLM). At a median follow up of 28 months, 20/33 patients were dead of disease, 8 were alive with disease and 5 were alive with no e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f94e651a9665b950e43aa435d900d8a
https://europepmc.org/articles/PMC5214751/
https://europepmc.org/articles/PMC5214751/
Autor:
Stefania De Luca, Giuseppe Castello, Antonio Luciano, Claudio Arra, Stefania Scala, Rosa Maria Vitale, Maria Napolitano, Caterina Ieranò, Mariana Gala, Crescenzo D'Alterio, Marianeve Polimeno, Domenica Rea, Rosa Calemma, Luigi Portella, Giuseppe De Palma, Antonio Barbieri, Pietro Amodeo
Publikováno v:
Cancer Research. 72:4645-4645
The interaction between the chemokine receptor CXCR4 and its ligand, CXCL12, has been shown in pre-clinical models to facilitate tumour metastasis and to be involved in tissue repair and in recruitment of hematopoietic precursors. AMD3100, a potent C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::843559f9d5470dd5c80badeb7869f4cc
https://doi.org/10.1158/1538-7445.am2012-4645
https://doi.org/10.1158/1538-7445.am2012-4645
Autor:
Rosa Maria Vitale, Elena Antignani, Gianpaolo Marcacci, Antonio Luciano, Anna Maria Riccio, Annamaria Trotta, Claudio Arra, Stefania Scala, Rosa Calemma, Marianeve Polimeno, Giuseppe Castello, Antonio Barbieri, Pietro Amodeo, Crescenzo D'Alterio, Stefania De Luca, Luigi Portella, Maria Napolitano, Marianna Gala
Publikováno v:
Cancer Research. 71:394-394
Introduction: The CXCR4 inhibitor AMD3100 is FDA-approved to provide stem cell mobilization for autologous transplantation in NHL and Multiple Myeloma patients. Newly designed CXCR4 inhibitory molecules, named Hys-7 inv, Phe-7 inv and Hys-OH, were re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8918e59f54b4a8717046906c273bc45
https://doi.org/10.1158/1538-7445.am2011-394
https://doi.org/10.1158/1538-7445.am2011-394
Autor:
Paolo Chiodini, S. Scala, S. Staibano, Giacomo Cartenì, Marianeve Polimeno, Nicola Longo, Mario Falsaperla, Giuseppe Castello, L. Cindolo, R. Franco, Antonio Gallo, Luigi Pucci, Crescenzo D'Alterio, L. Marra, V. Mirone, M. Mascolo, R.V. Iaffaioli, A. Riccio, L. Salzano
Publikováno v:
European Urology Supplements. 8:376
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::638dd817ef5401ae3450a0736d403125
https://doi.org/10.1016/s1569-9056(09)61006-x
https://doi.org/10.1016/s1569-9056(09)61006-x
Autor:
Giosuè Scognamiglio, Crescenzo D'Alterio, Anna Maria Riccio, Antonio Barbieri, Caterina Ieranò, Domenica Rea, Renato Franco, Stefania Scala, Luigi Portella, Claudio Arra, Marianeve Polimeno, Giuseppe Palma, Jane Bryce, Antonio Luciano
Publikováno v:
Cancer Immunology, Immunotherapy
Compelling evidence has emerged in recent years indicating that stromal cells play a critical role in disease progression. CXCR4 is a G-protein-coupled receptor with a major role in lymphocyte homing. Its ligand, CXCL12, is a highly efficient chemota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2950b385520df6e1387a9cf3cf0b838
Autor:
Luca Cindolo, Sisto Perdonà, Luigi Pucci, Renato Franco, Gaetano Facchini, Sandro Pignata, Stefania Scala, Luigi Marra, Alessandro Ottaiano, Susan Costantini, Giuseppe Castello, Michele Cioffi, Claudia Consales, L. Claudio, Giacomo Cartenì, Rosa Calemma, Marianeve Polimeno, Nicola Longo, Luigi Portella, Crescenzo D'Alterio
Publikováno v:
Scopus-Elsevier
CXCR4 is a chemokine receptor implicated in the metastatic process. The CXCR4 ligand, CXCL12, was shown to bind also the CXCR7 receptor, a recently deorphanized chemokine receptor whose signalling pathway and function are still controversial. This st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ed225b8292bf6246fb13dcd713fb6ad
http://www.scopus.com/inward/record.url?eid=2-s2.0-78649256331&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-78649256331&partnerID=MN8TOARS
Autor:
Crescenzo D'Alterio, Luca Cindolo, Claudia Consales, Giacomo Cartenì, L. Claudio, Anna Maria Riccio, Massimo Mascolo, Luigi Marra, Michele Cioffi, Vincenzo Mirone, Luigi Portella, Vincenzo Ficarra, Guido Martignoni, Paolo Chiodini, Stefania Staibano, Nicola Longo, Sisto Perdonà, Renato Franco, Mario Falsaperla, Stefania Scala, Giuseppe Castello, Marianeve Polimeno, M. Puglisi
Publikováno v:
Europe PubMed Central
The chemokine receptor CXCR4 and CD133, putative stem cell markers, were previously described in renal cancer (RCC). To evaluate the biological and prognostic role of CD133 and CXCR4 in RCC the expression was evaluated through qPCR and immunoblotting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f53992b00227274ec7387610b506a16
http://europepmc.org/abstract/med/21127401
http://europepmc.org/abstract/med/21127401